- Home
- GOCO vs GNTA Comparison
GOCO vs GNTA Comparison
Compare GOCO & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOCO
- GNTA
- Stock Information
- Founded
- GOCO 2001
- GNTA 2014
- Country
- GOCO United States
- GNTA Italy
- Employees
- GOCO N/A
- GNTA N/A
- Industry
- GOCO Specialty Insurers
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GOCO Finance
- GNTA Health Care
- Exchange
- GOCO Nasdaq
- GNTA Nasdaq
- Market Cap
- GOCO 70.3M
- GNTA 59.7M
- IPO Year
- GOCO 2020
- GNTA 2021
- Fundamental
- Price
- GOCO $3.96
- GNTA $2.57
- Analyst Decision
- GOCO Hold
- GNTA
- Analyst Count
- GOCO 1
- GNTA 0
- Target Price
- GOCO $12.00
- GNTA N/A
- AVG Volume (30 Days)
- GOCO 38.6K
- GNTA 1.9M
- Earning Date
- GOCO 11-06-2025
- GNTA 01-01-0001
- Dividend Yield
- GOCO N/A
- GNTA N/A
- EPS Growth
- GOCO N/A
- GNTA N/A
- EPS
- GOCO N/A
- GNTA N/A
- Revenue
- GOCO $822,444,000.00
- GNTA N/A
- Revenue This Year
- GOCO $2.06
- GNTA N/A
- Revenue Next Year
- GOCO $5.47
- GNTA N/A
- P/E Ratio
- GOCO N/A
- GNTA N/A
- Revenue Growth
- GOCO 17.46
- GNTA N/A
- 52 Week Low
- GOCO $3.89
- GNTA $2.33
- 52 Week High
- GOCO $21.00
- GNTA $10.00
- Technical
- Relative Strength Index (RSI)
- GOCO 28.41
- GNTA 44.60
- Support Level
- GOCO $4.32
- GNTA $2.33
- Resistance Level
- GOCO $4.54
- GNTA $10.00
- Average True Range (ATR)
- GOCO 0.19
- GNTA 0.63
- MACD
- GOCO -0.03
- GNTA -0.09
- Stochastic Oscillator
- GOCO 8.20
- GNTA 3.13
About GOCO GoHealth Inc.
GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.